SavedAdd your journal

Journals / İzmir Dr. Behçet Uz Çocuk Hastanesi Dergisi / 2017 / Cilt: 7 - Sayı: 1

A rarely seen case of exercise-induced cardiac arrest: A case with catecholaminergic polymorphic ventricular tachycardia

Efora bağlı nadir kardiyak arrest: Katekolaminerjik polimorfik ventriküler taşikardili bir olgu

Şevket BALLI
EVİÇ ZEYNEP AKGÜN
İlker Kemal YÜCEL
Mustafa Orhan BULUT
Gökmen AKGÜN
Emine Hekim YILMAZ
Taliha ÖNER
Ahmet ÇELEBİ
Pages
65–68
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In patients with CPVT exercise-induced syncope and family history are important factors in the establishment of diagnosis herein we wanted to emphasize the diagnosis and treatment of CPVT.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this report, we present a 15-year-old girl with catecholaminergic polymorphic ventricular tachycardia who had cardiac resuscitation due to cardiac arrest and her sister had died from cardiac arrest.
📊
Key Findings & Data:Catecholaminergic polymorphic ventricular tachycardias (CPVT), without structural cardiac abnormalities, can lead to sudden cardiac arrest during exercise or exertion.
💡
Conclusion & Impact:In patients with CPVT exercise-induced syncope and family history are important factors in the establishment of diagnosis herein we wanted to emphasize the diagnosis and treatment of CPVT.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

In this report, we present a 15-year-old girl with catecholaminergic polymorphic ventricular tachycardia who had cardiac resuscitation due to cardiac arrest and her sister had died from cardiac arrest. Catecholaminergic polymorphic ventricular tachycardias (CPVT), without structural cardiac abnormalities, can lead to sudden cardiac arrest during exercise or exertion. In patients with CPVT exercise-induced syncope and family history are important factors in the establishment of diagnosis herein we wanted to emphasize the diagnosis and treatment of CPVT.

Özet

Biz burada 15 yaşında katekolaminerjik polimorfik ventriküler taşikardiye ( KPVT) bağlı kardiyak arrest nedeniyle resüsitasyon yapılmış, kardeşi efor esnasında kardiyak arrest nedeniyle ex olmuş bir olguyu sunduk. KPVT de hastaların kardiyak yapısal bir bozukluğu olmamasına rağmen, egzersiz ya da efor sırasında kardiyak arreste neden olabilmektedir. KPVT'li hastalarda efor sırasında senkop ve aile öyküsü tanıda önemlidir. Biz burada KPVT'li hastaların tanı ve tedavisini vurgulamak istedik.

🔖

Cite This Article

BALLI, Ş., AKGÜN, E. Z., YÜCEL, İ. K., BULUT, M. O., AKGÜN, G., YILMAZ, E. H., ÖNER, T., ÇELEBİ, A. (2017). A rarely seen case of exercise-induced cardiac arrest: A case with catecholaminergic polymorphic ventricular tachycardia. İzmir Dr. Behçet Uz Çocuk Hastanesi Dergisi, Cilt: 7 - Sayı: 1, 65–68. https://ajindex.com/articles/197674

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Pflaumer A, Davis S. Guidelines for the diagnosis and management of catecholaminergic polymorphic ventricular tachycardia. Heart Lung Circ 2012;21:96-100.
  2. Leenhardt A, Lucet V, Denjoy I, Grau F, Ngoc DD, Cozumel P. Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation 1995;91:1512-9.
  3. Postma AV, Denjoy I, Kamblock J, Alders M, Lupoglazoff JM, Vaksmann G, Dubosq-Bidot L, Sebillon P, Mannens MM, Guicheney P, Wilde AA. Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients. J Med Genet 2005;42:863-70.
  4. Aizawa Y, Komura S, Okada S, Chinushi M, Aizawa Y, Morita H, Ohe T. Distinct U wave changes in patients with catecholaminergic polymorphic ventricular tachycardia 5. Napolitano C, Priori SG, Bloise R. Catecholaminergic polymorphic ventricular tachycardia. Gene Reviews 1993-2016
  5. Priori SG, Napolitano C, Memmi M, Colombi B, Drago F, Gasparini M, DeSimone L, Coltorti F, Bloise R, Keegan R, Cruz Filho FE, Vignati G. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 2002;106:69-74.
  6. Priori SG, Napolitano C. Role of genetic analysis in cardiology: part I: mendelian diseases: cardiac channelopathies. Circulation 2006;113:1130-5.
  7. Hayashi M, Denjoy I, Extramiana. Incidence and risk factors or arrhythmic event in catecholaminergic polymorphic ventricular tachycardia. Circulation 2009;119-2426-34
  8. Van der Werf C, Kannankeril PJ, Sacher F, Krahn AD, Viskin S, Leenhardt A et al. Flecainide therapy reduces exerciseinduced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia. J Am Coll Cardiol 2011;57:2244-54.
  9. Sumitomo N, Harada K, Nagashima M, Yasuda T, Nakamura Y, Aragaki Y et al. Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death. Heart 2003;89:66-70.
  10. Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited prima